These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 26657223

  • 1. Striatal Dopamine D2/D3 Receptor Availability Is Associated with Executive Function in Healthy Controls but Not Methamphetamine Users.
    Ballard ME, Dean AC, Mandelkern MA, London ED.
    PLoS One; 2015; 10(12):e0143510. PubMed ID: 26657223
    [Abstract] [Full Text] [Related]

  • 2. Low Dopamine D2/D3 Receptor Availability is Associated with Steep Discounting of Delayed Rewards in Methamphetamine Dependence.
    Ballard ME, Mandelkern MA, Monterosso JR, Hsu E, Robertson CL, Ishibashi K, Dean AC, London ED.
    Int J Neuropsychopharmacol; 2015 Jan 20; 18(7):pyu119. PubMed ID: 25603861
    [Abstract] [Full Text] [Related]

  • 3. Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity.
    Lee B, London ED, Poldrack RA, Farahi J, Nacca A, Monterosso JR, Mumford JA, Bokarius AV, Dahlbom M, Mukherjee J, Bilder RM, Brody AL, Mandelkern MA.
    J Neurosci; 2009 Nov 25; 29(47):14734-40. PubMed ID: 19940168
    [Abstract] [Full Text] [Related]

  • 4. Effect of Exercise Training on Striatal Dopamine D2/D3 Receptors in Methamphetamine Users during Behavioral Treatment.
    Robertson CL, Ishibashi K, Chudzynski J, Mooney LJ, Rawson RA, Dolezal BA, Cooper CB, Brown AK, Mandelkern MA, London ED.
    Neuropsychopharmacology; 2016 May 25; 41(6):1629-36. PubMed ID: 26503310
    [Abstract] [Full Text] [Related]

  • 5. Low Striatal Dopamine D2-type Receptor Availability is Linked to Simulated Drug Choice in Methamphetamine Users.
    Moeller SJ, Okita K, Robertson CL, Ballard ME, Konova AB, Goldstein RZ, Mandelkern MA, London ED.
    Neuropsychopharmacology; 2018 Mar 25; 43(4):751-760. PubMed ID: 28664927
    [Abstract] [Full Text] [Related]

  • 6. Midbrain functional connectivity and ventral striatal dopamine D2-type receptors: link to impulsivity in methamphetamine users.
    Kohno M, Okita K, Morales AM, Robertson CL, Dean AC, Ghahremani DG, Sabb FW, Rawson RA, Mandelkern MA, Bilder RM, London ED.
    Mol Psychiatry; 2016 Nov 25; 21(11):1554-1560. PubMed ID: 26830141
    [Abstract] [Full Text] [Related]

  • 7. Striatal dopamine D1-type receptor availability: no difference from control but association with cortical thickness in methamphetamine users.
    Okita K, Morales AM, Dean AC, Johnson MC, Lu V, Farahi J, Mandelkern MA, London ED.
    Mol Psychiatry; 2018 May 25; 23(5):1320-1327. PubMed ID: 28894300
    [Abstract] [Full Text] [Related]

  • 8. Emotion dysregulation and amygdala dopamine D2-type receptor availability in methamphetamine users.
    Okita K, Ghahremani DG, Payer DE, Robertson CL, Dean AC, Mandelkern MA, London ED.
    Drug Alcohol Depend; 2016 Apr 01; 161():163-70. PubMed ID: 26880595
    [Abstract] [Full Text] [Related]

  • 9. Association of Stimulant Use With Dopaminergic Alterations in Users of Cocaine, Amphetamine, or Methamphetamine: A Systematic Review and Meta-analysis.
    Ashok AH, Mizuno Y, Volkow ND, Howes OD.
    JAMA Psychiatry; 2017 May 01; 74(5):511-519. PubMed ID: 28297025
    [Abstract] [Full Text] [Related]

  • 10. Decreased dopamine activity predicts relapse in methamphetamine abusers.
    Wang GJ, Smith L, Volkow ND, Telang F, Logan J, Tomasi D, Wong CT, Hoffman W, Jayne M, Alia-Klein N, Thanos P, Fowler JS.
    Mol Psychiatry; 2012 Sep 01; 17(9):918-25. PubMed ID: 21747399
    [Abstract] [Full Text] [Related]

  • 11. Socioeconomic status is associated with striatal dopamine D2/D3 receptors in healthy volunteers but not in cocaine abusers.
    Wiers CE, Shokri-Kojori E, Cabrera E, Cunningham S, Wong C, Tomasi D, Wang GJ, Volkow ND.
    Neurosci Lett; 2016 Mar 23; 617():27-31. PubMed ID: 26828302
    [Abstract] [Full Text] [Related]

  • 12. D2/D3 dopamine receptor binding with [F-18]fallypride correlates of executive function in medication-naïve patients with schizophrenia.
    Vyas NS, Buchsbaum MS, Lehrer DS, Merrill BM, DeCastro A, Doninger NA, Christian BT, Mukherjee J.
    Schizophr Res; 2018 Feb 23; 192():442-456. PubMed ID: 28576546
    [Abstract] [Full Text] [Related]

  • 13. Similar striatal D2/D3 dopamine receptor availability in adults with Tourette syndrome compared with healthy controls: A [(11) C]-(+)-PHNO and [(11) C]raclopride positron emission tomography imaging study.
    Abi-Jaoude E, Segura B, Obeso I, Cho SS, Houle S, Lang AE, Rusjan P, Sandor P, Strafella AP.
    Hum Brain Mapp; 2015 Jul 23; 36(7):2592-601. PubMed ID: 25788222
    [Abstract] [Full Text] [Related]

  • 14. Prefrontal and striatal dopamine D2/D3 receptors correlate with fMRI BOLD activation during stopping.
    Pfeifer P, Sebastian A, Buchholz HG, Kaller CP, Gründer G, Fehr C, Schreckenberger M, Tüscher O.
    Brain Imaging Behav; 2022 Feb 23; 16(1):186-198. PubMed ID: 34403039
    [Abstract] [Full Text] [Related]

  • 15. Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson's disease with mild cognitive impairment.
    Christopher L, Marras C, Duff-Canning S, Koshimori Y, Chen R, Boileau I, Segura B, Monchi O, Lang AE, Rusjan P, Houle S, Strafella AP.
    Brain; 2014 Feb 23; 137(Pt 2):565-75. PubMed ID: 24334314
    [Abstract] [Full Text] [Related]

  • 16. Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study.
    Boileau I, Payer D, Houle S, Behzadi A, Rusjan PM, Tong J, Wilkins D, Selby P, George TP, Zack M, Furukawa Y, McCluskey T, Wilson AA, Kish SJ.
    J Neurosci; 2012 Jan 25; 32(4):1353-9. PubMed ID: 22279219
    [Abstract] [Full Text] [Related]

  • 17. Correlation of striatal dopamine D2/3 receptor availability with GABA level in the anterior cingulate cortex in healthy controls but not in alcohol-dependent subjects and individuals at high risk: A multimodal magnetic resonance spectroscopy and positron emission tomography study.
    Spitta G, Gleich T, Rosenthal A, Schubert F, Aydin S, Heinz A, Buchert R, Gallinat J.
    Addict Biol; 2024 Jun 25; 29(6):e13424. PubMed ID: 38899357
    [Abstract] [Full Text] [Related]

  • 18. Heightened Dopaminergic Response to Amphetamine at the D3 Dopamine Receptor in Methamphetamine Users.
    Boileau I, Payer D, Rusjan PM, Houle S, Tong J, McCluskey T, Wilson AA, Kish SJ.
    Neuropsychopharmacology; 2016 Dec 25; 41(13):2994-3002. PubMed ID: 27353309
    [Abstract] [Full Text] [Related]

  • 19. Gray-matter volume, midbrain dopamine D2/D3 receptors and drug craving in methamphetamine users.
    Morales AM, Kohno M, Robertson CL, Dean AC, Mandelkern MA, London ED.
    Mol Psychiatry; 2015 Jun 25; 20(6):764-71. PubMed ID: 25896164
    [Abstract] [Full Text] [Related]

  • 20. Relationship of Alexithymia Ratings to Dopamine D2-type Receptors in Anterior Cingulate and Insula of Healthy Control Subjects but Not Methamphetamine-Dependent Individuals.
    Okita K, Ghahremani DG, Payer DE, Robertson CL, Mandelkern MA, London ED.
    Int J Neuropsychopharmacol; 2016 May 25; 19(5):. PubMed ID: 26657175
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.